Genomic data in combination with clinical data will enable the provision of novel healthcare services and products, which are individualized (personalized medicine). In addition, genomic data contain valuable information for the research and development of personalized drugs.

Rolling out genomics into healthcare will open up opportunities to study the genetic and molecular components of health and disease on an unprecedented scale once ethical and regulatory, technical, societal and security challenges are taken care of.

Building genomics: genomDE - National and European initiatives conference, on 30th November 2020 (PDF-file - not barrier free, 858 KB), was an opportunity for high-level joint reflection on the most relevant national and European initiatives in genomics in the frame of the presentation fo the genomDE initiative to a professional audience for the first time.

Stakeholders across the scientific, healthcare, academic, political and managerial organisations, were invited to join the debate for genomics and contribute for the establishment of genomDE. The event also provided a forum for discussion on the challenges and opportunities linked to the implementation and management of genomics, as well as the analysis of the transferability and adaptability of the best practices in genomics to the German Health System.

The Building genomics: genomDE - National and European initiatives conference was a virtual event and participants were able to contribute to the discussion online and meet speakers through virtual networking opportunities.

• Highlights of the conference
  pptx-Datei (not barrier free, 2,82 MB)

• Infographic: Building genomics - genomDE - National and European initiatives
  PDF-file (not barrier free, 1,51 MB)

• Video recordings of the conference